Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • EcoClear Products to Showcase and Attend AAHOA Central Midwest Regional Conference and Trade Show
    EcoClear Products to Showcase and Attend AAHOA Central Midwest Regional Conference and Trade Show Business
  • Bookkeeping, Financial Auditing and Other Accounting Services Market Set For 4.4% Growth, Reaching 3.7 Billion
    Bookkeeping, Financial Auditing and Other Accounting Services Market Set For 4.4% Growth, Reaching $673.7 Billion World News
  • CORRECTION: Bona Fide Masks Corp., Exclusive U.S. Distributor of Powecom® KN95 Masks, Responds to Latest COVID-19 Surge With Distribution of Free KN95s in NYC
    CORRECTION: Bona Fide Masks Corp., Exclusive U.S. Distributor of Powecom® KN95 Masks, Responds to Latest COVID-19 Surge With Distribution of Free KN95s in NYC Business
  • FAA Seeks Public Input on New Control Towers for Municipal, Smaller Airports
    FAA Seeks Public Input on New Control Towers for Municipal, Smaller Airports Aviation
  • Meritus Media Unveils Visionary Approach to Brand Visibility in the Age of AI and Google’s E.E.A.T.
    Meritus Media Unveils Visionary Approach to Brand Visibility in the Age of AI and Google’s E.E.A.T. Business
  • Veterinary CRO And CDMO Market Analysis With opportunity segments
    Veterinary CRO And CDMO Market Analysis With opportunity segments Business
  • War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych  & #Feygin
    War Day 182: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Civil Rights Attorney and Child Advocate Areva Martin Speaks on Florida’s Curriculum to Teach Black History in Schools
    Civil Rights Attorney and Child Advocate Areva Martin Speaks on Florida’s Curriculum to Teach Black History in Schools World News
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

Posted on March 20, 2023 By NewsEditor
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaGB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaAccording to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences.

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China
Patent


LAS VEGAS, March 20, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates. Gb Sciences' first international patent also confirms that the Company's intellectual property strategy can work globally and strengthens the Company's patent portfolio. The global market for treatments of Parkinson's disease is projected to grow to $8.8 billion by the year 2026, and new therapies to address Parkinson's disease symptoms are greatly needed.

"The issuance of Gb Sciences' first international patent protecting methods of using our proprietary cannabinoid-containing formulations for treating Parkinson's disease is an important milestone in the development of these vitally important therapies. Gb Sciences' recent patent issued in China validates both our plant-inspired drug discovery process and intellectual property strategy, which involve defining and protecting Minimum Essential Mixtures," explained Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences, Inc. "Gb Sciences starts its drug discovery process with plant-based therapies that are working anecdotally or in traditional medical systems, then we systematically reduce the number of compounds to reveal Minimum Essential Mixtures. Gb Sciences' novel Minimum Essential Mixtures retain the increased efficacy of whole plant medicines, but they are easier to manufacture with precision at scale like single ingredient drugs. These Minimum Essential Mixtures are a viable alternative to standard single ingredient drugs or traditional whole plant medicines."

Gb Sciences' Minimum Essential Mixture-based drug development strategy does not aim to treat complex diseases as if they were caused by a single factor, but instead addresses the combination of factors that lead to a complex human disorder. Minimum Essential Mixtures (MEMs) are potentially more effective than single ingredient drugs because the different active ingredients target the multiple human processes responsible for complex diseases, such as neurodegeneration, heart disease, and cancers. As such, MEMs may offer a more holistic treatment for complex disorders such as Parkinson's disease that cannot be attributed to a single cause, while maintaining the manufacturing and quality control advantages of single ingredient drugs.

Gb Sciences' patent portfolio currently contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications that cover our novel AI-enabled drug discovery platform and proprietary plant-inspired therapies for more than 65 different disorders. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

The post GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China first appeared on Social Gov.

Business

Post navigation

Previous Post: War Day 220: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
Next Post: War Day 219: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin

Related Posts

  • Flex Technology Group Continues National Expansion With Advance Business Systems
    Flex Technology Group Continues National Expansion With Advance Business Systems Business
  • Entrex Carbon Market Initiates Regulatory Review Request with FINRA and SEC Due to Delays in Corporate Actions
    Entrex Carbon Market Initiates Regulatory Review Request with FINRA and SEC Due to Delays in Corporate Actions Business
  • Siteline Construction Group Launches Company Rebrand and Designer Showroom
    Siteline Construction Group Launches Company Rebrand and Designer Showroom Business
  • Nicotine Addiction Treatment Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    Nicotine Addiction Treatment Market Size, Share, Revenue, Trends And Drivers For 2023-2032 Business
  • Signals Announces Live Sessions for Upcoming RevTech Summit on Feb. 15
    Signals Announces Live Sessions for Upcoming RevTech Summit on Feb. 15 Business
  • POSITIVE FORCES OF THE WORLD UNITE, CELEBRATING 50 YEARS OF GLOBAL INITIATIVES SAT., DEC. 30, 2023 IN TIMES SQUARE
    POSITIVE FORCES OF THE WORLD UNITE, CELEBRATING 50 YEARS OF GLOBAL INITIATIVES SAT., DEC. 30, 2023 IN TIMES SQUARE Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • AV8 Realty Unveils Revolutionary FBO LeaseMAX and PlaneMAX Solutions at NBAA-BACE 2025October 25, 2025
  • Golf Simulator Market: Future Demand and Top Key Players AnalysisOctober 25, 2025
  • Gene Circuit Therapeutics Market Set to Reach $4.11 Billion by 2029October 24, 2025
  • Gould Academy Engineering Club Selected to Compete in NASA CompetitionOctober 24, 2025
  • Navigation Satellite System (GNSS)-Independent Positioning, Navigation, And Timing Constellation Market Trends 2025-2029October 24, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • VenueArc, A SaaS Venue Booking and Event Management Software Dedicated to Performing Arts Centers
    VenueArc, A SaaS Venue Booking and Event Management Software Dedicated to Performing Arts Centers World News
  • FAA Expands B4UFLY Services for Drone Pilots
    FAA Expands B4UFLY Services for Drone Pilots Aviation
  • Secretary Blinken’s Call with UN Secretary-General Guterres
    Secretary Blinken’s Call with UN Secretary-General Guterres World News
  • Day 409: war diaries w/Former Advisor to Ukraine President, Intel Officer  @arestovych  & #Feygin
    Day 409: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Day 385: war diaries w/Former Advisor to Ukraine President, Intel Officer  @arestovych  & #Feygin
    Day 385: war diaries w/Former Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
  • Global Frozen, Canned, and Dried Food Market Flourishes with Sustainable and Organic Trends
    Global Frozen, Canned, and Dried Food Market Flourishes with Sustainable and Organic Trends World News
  • Dive into Chicago with HotelCheckin18Plus.com’s “7 Must-Do Experiences”
    Dive into Chicago with HotelCheckin18Plus.com’s “7 Must-Do Experiences” World News
  • How to Enjoy Home Comfort Outdoors With OUKITEL P2001 Portable Power Station
    How to Enjoy Home Comfort Outdoors With OUKITEL P2001 Portable Power Station Business
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .